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ABSTRACT-The synthesis of various products by a human 
mammary cell line (BT 20) was studied by Incorporation of "C-
labeled amino acids, choline, glucosamlne, or galactosamine Into 
nondlalyzable materials. These products had molecular weights 
ranging from less than 12,300 daltons to more than 200,000 
daltons. They were analyzed by Immunoelectrophoresls and 
double diffusion In agar. Among the synthesized products, the 
following proteins were identified: ~2-glycoproteln I, lX2HS-glyco-
protein, (wlipoproteln, actin, ~2-mlcroglobulln, carclnoembryonlc 
antigen, three oncofetal-associated antigens, and various eryth-
rocyte membrane-associated antigens (namely, glycophorin). 
Synthesis of milk proteins was not detectable. Only the protein 
moiety of the glycophorln molecule seemed to be synthesized. 
The ~2-mlcroglobulin was synthesized in an unbound state as 
well as bound to a glycoprotein whose relationship with the 
transplantation or tumor antigens must be determined. The three 
oncofetal-associated antigens were also synthesized in vitro by 
human fetal tissues and neoplastic and dysplastic human mam-
mary tissues.-J Natl Cancer Inst 61: 677-686, 1978. 
Tumor-associated antigens are present on breast 
carcinoma cells. The evidence supporting the existence 
of such antigens is based largely on the demonstration 
of lymphocytes and antibodies against carcinoma cells 
and carcinoma extracts in patients with breasl carci-
noma (1-7). Extracts from breast carcinoma and from a 
breast carcinoma cell line (MC.F-7) have also been 
shown to inhibit the migration of leukocytes from 
patients with breast carcinoma (8-10). Several attempts 
have been made to purify the tumor-associated anti-
gens, but the results have been too different to allow 
any comparison (11-16). Essentially, these diverse re-
sults can be explained by the heterogeneity of the 
starting material and the difficulty in the solubilization 
of membrane-associated antigens. However, investiga-
tors have shown that several proteins are released in 
the culture fluids or can be isolated from cells of 
various tumor cell lines from human or animal origin 
and that some of these proteins are tumor-associated 
antigens (17-22). 
Isolation of various products synthesized by breast 
carcinoma cell lines could be important, inasmuch as 
these products might be used as carcinoma markers. 
Also, the purification of breast carcinoma tumor-
associated antigens released in the culture fluids by 
these cell lines would be useful for immunodiagnosis 
and productlon of specific antisera. 
In this study, we have attempted to analyze the 
products synthesized by a human mammary cell line 
(BT 20) for two reasons: 1) The starting material 
consisted only of tumor cells and was constant and 
reproducible; 2) several products released in the culture 
fluids of this cell line were soluble, therefore making it 
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unnecessary to use solubilization techniques which are 
difficult and denaturing. We selected the BT 20 cell 
line because it seemed to have kept the properties of a 
breast carcinoma. These cells have an ultrastructure 
similar to that of the original tumor (23). When 
transplanted into nude mice. they produce tumors 
morphologically similar to the original mammary 
carcinoma (24). They can be used as target cells in 
cytotoxicity tests (4). 
We studied the synthesis of several products in this 
cell line by incorporation of labeled amino acids. 
choline, galactosamine, and glucosamine into nondia-
lyzable materials. These products were analyzed by 
immunoelectrophoresis and double diffusion in agar 
with antisera against serum, milk, and membrane-
associated and oncofetal-associated antigens. 
MATERIALS AND METHODS 
Antigens.-Human milk was obtained from the 
Department of Gynecology and Obstetrics, University 
of Lausanne. Free secretory component was prepared 
from human milk by the method of Brandtzaeg (25). 
Lactoferrin was isolated from human milk (26). Lact-
albumin was purified according to the method of 
Kaplanas and Antanavichyns (27). The milk fraction 
rich in P2-microglobulin used as carrier for autoradio-
graphs was isolated from milk. Human lactoserum was 
fractionated on a Sephadex G-200 column. The last 
fraction was chromatographed on a DEAE-cellulose 
column equilibrated with 0.01 M (pH 7.0) phosphate 
buffer. After the first protein peak had been obtained, 
the remaining proteins were eluted by a linear NaCl 
gradient in the starting buffer. The fractions rich in Pr 
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microglobulin were pooled. Acid-precipitated casein 
from human milk was chromatographed on a DEAE-
cellulose column by the method of Nagasawa et al. 
(28). Fraction 5 was used, which corresponds to a 
fraction of the /3-casein group. Spectrin and glyco-
phorin were gifts from Dr. C. Bron, Department of 
Biochemistry, University of Lausanne. CEA and BOFA 
were gifts from Dr. J. P. Mach, Department of Bio-
chemistry, University of Lausanne. Actin was a gift 
from Dr. G. Gabbiani, Department of Pathology, 
University of Geneva, Geneva, Switzerland. Human 
placenta lactogen and /3ISP-glycoprotein were obtained 
from Behringwerke, Marburg, Federal Republic of 
Germany. Human ferritin (/3-fetoprotein) and human 
serum negative for /3-fetoprotein were obtained from 
Bioware Inc., Wichita, Kansas. 
Antisera.-Antisera against free secretory compo-
nent, lactoferrin, milk, casein, and lactalbumin were 
produced in rabbits weighing 2.5-3 kg. The rabbits 
were immunized im each week with 500 p,g of protein 
in I ml saline in emulsion with an equal part of 
Freund's complete adjuvant. They were bled I week 
after receiving the third injection. 
To render them specific, the antisera were absorbed 
with various proteins from human milk and/or human 
serum. Each of these antisera was tested by immuno-
electrophoresis and by double diffusion .. in agar against 
human serum and human milk. Antiserum against free 
secretory component gave one line against lactoserum 
with a cathodal spur corresponding to the bound 
secretory component. Antisera against lactalbumin, 
casein, and lactoferrin gave a single line against milk. 
The antimilk serum gave several lines against milk but 
no lines against human serum. 
Antisera against BT 20 cells were obtained by immu-
nization of rabbits with BT 20 cells cultured during 9 
days without FCS and prepared as described later in 
"Tissue cultures" (sample 4). The immunization 
method was as described for milk proteins. The unab-
sorbed anti-BT 20 antisera did not reveal human milk 
or serum proteins nor did they reveal FCS proteins 
when tested by double diffusion in agar and by 
immunoelectrophoresis with various concentrations of 
human serum, human milk, and FCS. 
Antisera against spectrin and glycophorin were gifts 
from Dr. C. Bron, Department of Biochemistry, Uni-
versity of Lausanne. Two antiglycophorin antisera 
were used. One of the antisera was obtained in a rabbit 
by immunization with glycophorin isolated according 
to the method of Tillack et al. (29). The other was 
obtained in a rabbit by immunization with a glyco-
phorin fraction obtained upon electrophoresis of this 
protein in SDS polyacrylamide gel. The 2 antisera were 
absorbed with polymerized human plasma and blood 
groups A and B (30). Both antisera revealed only the 
glycophorin line in immunoelectrophoresis with red 
blood cell ghosts solubilized in Nonidet P-40. Al-
though the first of these antisera perhaps contained 
antibodies against actin, spectrin, and band 3 of red 
blood cell ghosts electrophoresed in SDS-polyacryla-
mide gel, the second seemed to be specific for glyco-
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phorin (31). The antiserum specific for spectrin was 
obtained by immunization of rabbits with a spectrin 
fraction obtained by electrophoresis of red blood cell 
stroma in SDS-polyacrylamide 5% gel. This antiserum 
was specific for spectrin as shown by two-dimensional 
immunoelectrophoresis with red blood cell stroma. 
Antiserum against BOFA was a gift from Dr. J. P. 
Mach. It has been characterized by Fritsche and Mach 
(32). Serum from a patient with chronic aggressive 
hepatitis was used as an antiactin antiserum and was 
obtained from Dr. G. Gabbiani. The specificity of this 
antiserum for actin has been shown by immunofluores-
cence and immunodiffusion (33). 
The following antisera were obtained commercially: 
swine antiserum polyvalent against human serum (Re-
search Institute for Immunology, Prague, Czechoslo-
vakia); rabbit antisera specific for al-fetoprotein, /3ISP-
glycoprotein, placental lactogen, /32-glycoprotein I. 
a 2HS-glycoprotein, ai-lipoprotein, ceruloplasmin. 
transferrin, haptoglobin, hemopexin, ai-acid glyco-
protein, /32-glycoprotein Ill, and /3-lipoprotein (Beh-
ringwerke, Marburg); rabbit antisera specific for eryth-
rocyte membrane, /32-microglobulin, and CEA (Dako-
patts, Copenhagen, Denmark); and rabbit antiserum 
specific for ferritin (Bioware Inc.). 
Tissue cultures.-The BT 20 cell line, originating 
from an infiltrating ductal breast carcinoma, was 
obtained from Dr. L. Ozzello. These cells were grown as 
monolayers in 25-cm2 plastic flasks (Falcon Plastics, 
Oxnard, CaliL) in medium RPMI-1640 supplemented 
with 2% FCS (Gibco-Biocult, Glasgow, Scotland). The 
BT 20 cultures were controlled three times for myco-
plasma during the study. They were mycoplasma-free 
at the beginning but were mycoplasma-positive after I 
year. New BT 20 cells free of mycoplasma wne 
obtained for our study. The material used for our study 
was obtained from mycoplasma-free cultures as well as 
from contaminated cultures. 
For incorporation studies, the cells, 24 hours after 
passage, were washed with Hanks' balanced salt solu-
tion without Ca2+ and Mg2+ (Gibco-Biocult) and cul-
tured with 3 ml of the adequate radioactive medium 
for 72 hours. Thereafter, the medium was collected 
(sample I), changed to RPMI-1640 medium without 
FCS, supplemented with I p,g hydrocortisone hydrogen 
succinate/ml and 20 p,g crystalline insulin/ ml, and 
cultured for 72 hours. This procedure was repeated 
once (samples 2 and 3). After the last collection of 
culture fluid, the cells were harvested in 3 ml of 
phosphate-buffered saline (pH 7.2) by their being 
scraped with a rubber policeman. The cell suspension 
was frozen and thawed twice and sonicated fOl I 
minute in the cold at an output power of 3S watts 
(Sonifier B 10; Branson Sonic Power Co., Danbul\, 
Conn.); it constituted sample 4. 
Several radioactive media were used. The\' consisted 
of a modified Eagle's nutrient mixture to which were 
added I p,g hydrocortisone hydrogen succinate/m\. 20 
p,g crystalline insulin/ml, 121 p,g crystalline sodium 
penicillin G/mJ. and 25 mM N-2-hydrox\'ethvlpipera-
zine-N'-2-ethanesulfonic acid. To this basic composi-
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tion various labeled products were added: 1) 0.5 JoLCi L-
[14C]lysine/ml plus 0.5 JoLCi L-[,4C]isoleucine/ml (1,200-
1,270 mCi/mmole); 2) 0.5 JoLCi L-[14C]arginine/ml plus 
0.5 JoLCi L-(14C]valine/ml (>225 mCi/mmole); 3) 0.5 JoLCi 
[methy/-,4C]choline/ml (40-60 mCi/mmole); 4) 0.5 JoLCi 
n-[ 14C]galacLOsamine hydrochloride/m I (>45 mCiI 
mmole); and 5) 0.5 JoLCi n-[14C]glucosamine hydrochlo-
ride/ml (>200 mCilmmole). All radiolabeled products 
were from Radiochemical Centre, Amersham, Bucking-
hamshire, England. 
Several flasks of BT 20 cells were incubated only in 
medium RPMI-1640 without FCS. The cells were 
treated as the cells incubated in radiolabeled medium. 
In several cullures, the radiolabeled medium and the 
RPMI-1640 medium were supplemented with 1) 50, 5, 
0.5, and 0.05 JoLg ovine prolactin/m I (NIH-P-SI0; 
kindly supplied by the National Institute of Arthritis 
and Metabolic Diseases, Bethesda, Md.); 2) 5, 1, and 0.1 
JoLg concanavalin A/ml (Calbiochem, La Jolla, Calif.); 
3) 10, 5, and 1 JoLI phytohemagglutinin P/ml (Difco 
Laboratories, Detroit, Mich.); and 4) 10, 5, and 1 JoLI 
pokeweed mitogen/ml (Grand Island Biological Co., 
Grand Island, N.Y.). 
Placentas, neoplastic and dysplastic human breast 
tissues, as well as liver, submandibular glands, intes-
tine, spleen, and lungs from human fetus were cullured 
in roller tubes as described previously (34). After 
cullure, all fluids were dialyzed against 0.005 M (pH 
8.6) barbital buffer and lyophilized. Before lyophiliza-
tion, the radioactivity of a IO-JoLI sample was counted 
on a filler paper in 2,5-diphenyloxazole-l,4-bis[2-(5-
phenyloxazolyl)]benzene toluol scintillation solution. 
The incorporation of the radioactive products into 
nondialyzable material was calculated by a comparison 
with the radioactivity of the medium before dialysis. 
The lyophilized powders from cullures with radio-
labeled medium were dissolved in 0.3 ml of distilled 
water, and the solutions were analyzed by autoradiog-
raphy of double diffusion and immunoelectrophoresis. 
To 50 JoLI of several concentrated cullure fluids from 
cullures with RPMI-1640 medium, 10 JoLI of a solution 
containing 2.5 JoLCi of [59Fe]ferrous citrate (>4 mCi 
Fe/mg; Eidgenossisches Institut fur Reaktorforschung, 
Wurenlingen, Switzerland) was added. The solutions 
were analyzed by autoradiography of electrophoresis in 
agarose and immunoelectrophoresis. 
Double diffusion in agar.-The micromethod was 
used in 2% agar in 0.025 M barbital buffer, pH 8.2. 
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Immunoelectrophoresis.-The micromethod of 
Scheidegger (35) was used with slight modifications for 
the LKB apparatus 6800 (LKB Products, Stockholm, 
Sweden). In double diffusion in agar and in 
immunoelectrophoresis, concentrated culture fluids 
were added with a carrier to the antigen wells. Various 
carriers and antisera were used according to the kind of 
protein to be demonstrated. 
Electrophoresis in agarose.-Electrophoresis was 
made in agarose placed on a film of polyester 
(Readyfilm; Mullener, Spreitenbach, Switzerland) in 
0.05 M barbital buffer (pH 8.6). 
Polyacrylamide gel electrophoresis.-Cullure fluids 
were analyzed by electrophoresis in a 6% polyacryla-
mide slab gel containing 0.1 % SDS in 0.02 M phosphate 
buffer (pH 7.0). Several markers were also electro-
phoresed for an evaluation of the molecular weights: 
bovine serum albumin, ovalbumin (Pentex Inc., Kan-
kakee, IlL), and cytochrome c (Sigma Chemical Co., 
Saint Louis, Mo.). Each cullure fluid was run twice on 
the gel. In one case the gel was dried and autoradio-
graphed. In the other case it was cut along the length 
in 2-mm sections. Each fragment was digested over-
night at 65° C in a 15% NCS (Amersham/Searle Corp., 
Arlington Heights, Ill.) solution in ammonia and then 
counted in scintillation liquid. 
Autoradiography.-The immunoelectrophoresis and 
the double diffusion slides, the agarose electrophoresis 
slides, and dried SDS-polyacrylamide gel were placed 
in contact with photographic film (Kodak professional 
Royal Pan 400 ASA) for 14 or 42 days at room 
temperature. 
Trichloroacetic acid precipitation.-Twenty micro-
liters of several radioactive cullure fluids were incu-
bated with 25 JoLI of normal human serum to which was 
added 125 JoLI of 15% trichloroacetic acid. The precipi-
tate formed was washed twice with 15% trichloroacetic 
acid by repeated centrifugation. The washed precipitate 
was solubilized in 50-100 JoLI of 2 M NaOH and then 
transferred onto a filler paper. After drying, the filler 
paper was counted in scintillation liquid. 
RESULTS 
Incorporation of 14C-Labeled Products Into Non-
dlalyzable Material 
BT 20 cells incorporated radiolabeled products into 
TABLE I.-Incorporation of 14C-labeled products into nondialyzable material" 
Experimental details 
1 
[1'C]lysine+C'C]isoleucine, 5 expts, 5 flasks 6.17±O.86 
C4C]valine+[ 14 C]arginine, 2 expts, 3 flasks 4.03±O.92 
[14C]glucosarriine, 2 expts, 3 flasks 1.76±O.27 
[14 C ]galactosamine, 2 expts, 3 flasks 1.16±O.O3 
C4C]choline, 1 flask 1.45 
Incorporation in sample b 
2 3 
9.67±2.83 4.31±1.92 
4.67±O.65 4.43±O.88 
1.13±O.31 O.42±O.O8 
1.49±O.36 O.88±O.lO 
4.48 3.85 
4 
48.82±14.21 
ND 
3.38±O.72 
ND 
44.85 
Total 
69±14.4 
ND 
6.70±1.00 
ND 
54.6 
" The incorporation is expressed as the percentage of the initial radioactivity. The percentage is a mean of several experiments±sD. 
ND=not done. 
b Samples 1-3 correspond to culture fluids taken every 72 hr. Sample 4 is a harvest of the cultured cells after 9 days in culture. 
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nondialyzable material in amounts varying according 
to the product used and to the period of culture (table 
1). Precipitable by trichloroacetic acid was 84%±3.6% of 
the radioactivity of the nondialyzable material. 
With lysine and isoleucine used as 14C-labeled prod-
ucts, no significant difference in incorporation was 
seen between the BT 20 cells cultured in the radio-
labeled medium with or without concanavalin A, 
phytohemagglutinin, pokeweed mitogen, or ovine pro-
lactin. 
Analysis of the culture fluids by autoradiography of 
electrophoresis in agarose revealed various bands, de-
pending on the labeled products used and on the 
sampling time (fig. 1). Four bands were more anodal 
than albumin. Autoradiographs of SDS-polyacrylamide 
gel electrophoresis showed 14-19 bands varying from 
products that did not penetrate the gel [0 products 
having a molecular weight less than 12,300 daltons 
(cytochrome c). Several spots were common to the 4 
samples; others were present in 1 or 2 samples only 
(fig. 2). These observations were particularly outstand-
ing in the profiles of the graphs on radioactivity 
counts (text-fig. I). Two peaks corresponding to a 
molecular weight of 55,000 and 28,000 daltons were 
present in all 4 samples. Two peaks with molecular 
weights of 17,000 and 9,000 daltons were found in the 
first 3 samples, a peak of 85,000 daltons was found in 
all samples with the exception of sample 3, and a peak 
of 115,000 daltons was found in samples I and 2. 
Characterization of Products 
The products synthesized by BT 20 cells were ana-
lyzed by autoradiography of double diffusion and 
immunoelectrophoresis slides. These products could be 
classified as serum proteins, milk proteins, membrane-
associated proteins, and fetal proteins according to the 
antisera and carriers used. 
Serum Proteins 
In autoradiographs with normal human serum as 
carrier and with a swine antiserum polyvalent against 
serum proteins, 3-5 labeled lines were seen in culture 
fluid samples I and 2 from cells cultured with [14C]ly-
sine and [14C]isoleucine. These lines had an 0/- and p-
electrophoretic mobility in agar. No lines were visible 
in culture fluid samples 3 and 4. When the culture 
fluids were analyzed with the same antiserum but 
without carrier, none had any visible labeled line. 
For further characterization of these labeled lines, the 
culture fluids were analyzed with normal human serum 
as carrier against all the antisera specific for serum 
proteins mentioned in "Materials and Methods." Only 
culture fluid samples I and 2 gave labeled precipitation 
lines against 3 of the antisera used, namely, anti-p2-
glycoprotein I, anti-0/2HS-glycoprotein, and anti-O/r 
lipoprotein (fig. 3c). No lines were visible in culture 
fluids from cells cultured with choline or glucosamine. 
No change in the above results was seen in culture 
fluids from cells cultured in the same medium supple-
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mented with concanavalin A, phytohemagglutinin, 
pokeweed mitogen, and prolactin. 
Milk Proteins 
No evidence was seen of labeled lines corresponding 
to free secretory component, lysozyme. casein. or lact-
albumin. With rare culture fluids. the immunoprecipi-
tation line corresponding to lactoferrin was labeled. 
However. this line was not visible when the culture 
fluid was used alone. Autoradiographs of electrophore-
sis in agarose and immunoelectrophoresis of culture 
fluids did not reveal lactoferrin. 
Membrane-Associated Proteins 
Three to 5 labeled lines were revealed in all 4 culture 
fluids with an antiserum specific for erythrocyte mem-
brane (fig. 3a). A labeled line corresponding to glyco-
phorin was seen only when a carrier was used with 
culture fluids from cells cultured with 14C-Iabeled 
amino acids. No labeled line corresponded to spectrin 
(fig. 4). However. with spectrin. glycophorin. or actin 
as carriers and antisera against spectrin and glyco-
phorin. a labeled line not superposable on the precipi-
tation line of the carrier was seen. With the system 
actin-antiactin. a labeled line at the limit of visibility 
corresponded to the precipitation line of the carriel:. 
Whether the actin-Iabeled line was identical to that 
revealed by antispectrin and antiglycophorin sera could 
not be determined by double diJfusion in agar. 
A labled line corresponding to Prmicroglobulin was 
seen with or without the use of a P2-microglobulin 
carrier (fig. 3d). This labeled line was visible in 
samples I and 2 from cells cultured in a medium with 
[14C]lysine plus [i4C]isoleucine or [i4C]valine plus [14C]-
arginine but not from cells cultured in a medium with 
[14C]glucosamine. [14C]galactosamine. or [14C]choline. 
In some of the samples I and 2 analyzed without 
carrier. a second line. parallel to the P2-microglobulin 
line and closer to the antigen well. was seen. This 
second labeled line was present in culture fluids from 
cells cultured in a medium with [14C]lysine. [14C]galac-
tosamine, or in some cases with [14C]choline. 
Fetal Proteins 
A labeled line corresponding to CEA was seen only 
when CEA was used as carrier (figs. 5a. 5b). Synthesis 
of O/l-fetoprotein. anodal isoferritin. or BOF A was not 
detectable. 
In all culture fluids from BT 20 cells cultured with 
14C-Iabeled amino acids and analyzed without a carrier. 
1-3 radiolabeled lines were seen with 6 rabbit antisera 
against BT 20 cells. These lines corresponded to 
proteins that a~e also synthesized by human adult and 
fetal tissues (fig. 6). They were detected in all culture 
fluids from 5 placentas and from 17 fetal tissues 
originating from 6 different fetuses. in 9 culture fluids 
from 10 dysplastic breast tissues. and in 6 culture fluids 
from 11 breast carcinomas. Double diffusion in agar 
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TEXT.FIGURl. I.-Curves of the radioactivity counts of SDS poly-
acrylamide gel electrophoresis. Ten microliters of concentrated cul-
ture fluid from BT 20 cells cultured with [14C]lysine and p4C]iso-
leucine was applied per geL The positions of the markers are indi-
cated. Slices were cut to 2 mm in length. Top left: sample I; top 
right: sample 2; bottom left: sample 3; bottom right: sample 4. 
OV A=ovalbumin; BSA=bovine serum albumin; CYT=cytochrome 
c; C.P.M.=counts per min. 
revealed a complete identity between these lines and 
the lines of culture fluids from BT 20 cells. The 
absorption of the anti-BT 20 antisera by FCS and 
double diffusion in the presence of FCS did not change 
the results. No labeled lines were visible in culture 
fluids from BT 20 cells cultured in a medium with 
[14C]choline, [14C]glucosamine, or [14C]galactosamine. 
DISCUSSION 
BT 20 cells incorporate various labeled products into 
nondialyzable materials that are released in culture 
over a 9-day period. The difference between the radio-
activity in the nondialyzable materials and that in the 
precipitate obtained by trichloroacetic acid is probably 
VOL. 61, NO. 3, SEPTEMBER 1978 
Synthesis of Antigens by BT 20 Cells 681 
due to the presence of small peptides, Human breast 
cancer cells have been reported to have concanavalin A 
receptors (36). We have, therefore, tried to stimulate the 
BT 20 cells with concanavalin A and other lectins. 
These attempts, as well as attempted stimulation with 
prolactin, were unsuccessful. 
Several of the synthesized products have been identi-
fied. Of the 5 serum proteins, 3 have been characterized 
as ~rglycoprotein I, a2HS-glycoprotein, and arlipo-
protein, We previously showed that the labeling of 
these precipitation lines is not due to a nonspecific 
fixation of radiolabeled material to the immune precip-
itate (34). These serum proteins are also synthesized by 
dysplastic and neoplastic human mammary tissues (34), 
and some of them probably correspond to glycopro-
teins whose concentrations have been found elevated in 
the sera of patients with breast carcinoma (37, 38). 
Although these serum proteins have been found in 
high concentrations in various diseases and are 
thought to be produced by the liver (39), their synthesis 
by BT 20 cells necessitates a reconsideration of the role 
of the breast carcinoma itself in their production. 
Milk proteins were not detected in any of the culture 
fluids from the different labeled media used. We did 
not take into account the rare labeling of lactoferrin, 
inasmuch as we did not find any synthesized products 
able to fix 59Fe. 
Absence of synthesis of milk proteins could be due to 
several factors. Cells for the in vitro synthesis of these 
proteins possibly require a complex culture medium as 
noted by Flaxman (40) that does not correspond to our 
conditions of culture. Also, BT 20 cells may have lost 
some specific characteristics of differentiated mammary 
epithelium that have been kept in another cell line, 
MCF-7 (41). However, most probably the original 
carcinoma cells were unable to synthesize milk pro-
teins. This had been shown to be so for many breast 
carcinomas. Casein was found by immunofluorescence 
in cells of 5 of 20 infiltrating ductal carcinomas of no 
special type (34). Monaco et al. (42) reported that only 
8 of 47 breast cancer tumors were positive for casein 
and that none of the 7 breast cancer cells tested 
synthesized casein in vitro. Kleinberg (43) also showed 
that only 4 of 19 breast cancer tissues cultured in vitro 
synthesized lactalbumin. This absence of synthesis of 
milk proteins has also been demonstrated in cultures of 
rat and mouse mammary carcinoma cells (44). To-
gether, these results suggest that most breast carcinoma 
cells in vitro and in vivo have lost their potential to 
synthesize milk proteins and that milk proteins are 
poor markers for most breast carcinomas. 
Several proteins present on the erythrocyte mem-
brane are synthesized by the BT 20 cells, One of them 
is glycophorin, the major protein of the erythrocyte 
membrane described by Marchesi et al. (45). With an 
antiserum specific for erythrocyte membrane, the radio-
labeled lines are visible without the use of a carrier; 
however, the line revealed by an antiserum specific for 
glycophorin is labeled only when glycophorin is used 
as carrier. In contrast to the other carriers used in this 
study, glycophorin precipitated by its specific anti-
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serum captures unspecifically various labeled products. 
However, in these cases the radioactive line is just 
visible. The strong radiolabeled line of glycophorin 
with BT 20 culture fluids is in favor of a specific 
labeling. The necessity of using a carrier for the 
demonstration of glycophorin is perhaps due to the 
fact that the BT 20 cells synthesize only a part of the 
molecule of glycophorin as it exists in red blood cells. 
This molecule having only some of the antigenic 
determinants of glycophorin is probably not specific to 
the erythrocyte membrane but could be present on 
various other cells. This would further explain the 
immunologic cross-reaction between glycophorin and 
ai, a human cell-surface antigen (46). 
The in vitro synthesis of actin confirms the results 
obtained by immunofluorescence, which revealed the 
presence of actin in cells from several carcinomas and 
particularly from breast carcinomas (47, 48). The ab-
sence of spectrin synthesis is in accord with the results 
obtained by Hiller and Weber (49) with cultures of 
HeLa cells and fibroblasts. The samples of spectrin 
and glycophorin used are probably contaminated with 
small amounts of actin, and antisera specific for 
spectrin and one antiserum specific for glycophorin 
also reveal the antigenic determinants of actin. This 
could explain the fine labeled line obtained with these 
antisera when actin, spectrin, or glycophorin is used as 
carrier inasmuch as the labeled line is not superposable 
to the precipitation line. However, this hypothesis 
could not be proved by double diffusion in agar with 
the actin-antiactin system due to a labeling at the limit 
of visibility and the difficulty of having an adequate 
concentration of all the antisera and carriers on the 
same slide. 
BT 20 cells synthesize ,B2-microglobulin as do many 
other tumor cell lines (50). However, the detection of a 
second labeled line with an antiserum specific for ,B2-
microglobulin warrants further study. The position of 
this line near the antigen well and its curvature suggest 
that the line corresponds to a product heavier than ,Br 
microglobulin. Whereas the usual line of ,B2-micro-
globulin is labeled only with 14C-Iabeled amino acids, 
the supplementary line is labeled also with (14C]glu-
cosamine. These two observations taken together sug-
gest that the supplementary line corresponds to ,Br 
microglobulin associated with a glycoprotein which 
could be a transplantation antigen or a tumor-specific 
antigen. Thomson et al. (16) reported that antigenic 
tumor material from human breast cancer was associ-
ated with ,Brmicroglobulin, and Nakamuro et al. (51) 
demonstr<¥ed ,Brmicroglobulin in an unbound state 
and bound to HLA in several human cell lines. 
The BT 20 cells synthesize 4 fetal proteins, one of 
which is CEA. However, it is not possible to specify 
whether this protein is the CEA originally described by 
Gold and Freedman (52) or a breast carcinoma mem-
brane-associated antigen that shares antigenic deter-
minants with CEA as reported by Kuo et al. (11). Three 
other fetal proteins are detected by the anti-BT 20 cell 
antisera. These antisera detect only these proteins and 
no proteins specific to the BT 20 cells. Some or all of 
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these proteins could correspond to products synthesized 
by mycoplasma that contaminated some cultures. How-
ever, this does not seem to be the case inasmuch as the 
anti-BT 20 antisera show the same radiolabeled lines 
when tested with either the contaminated culture fluids 
or the mycoplasma-free culture fluids. Moreover, the 
same labeled lines are obtained with the use of antisera 
against BT 20 cells with culture fluids from various 
human tissues cultured for 48 or 72 hours only, in 
which there is little probability of a mycoplasma 
contamination. 
We have not evaluated the relationship between the 3 
other fetal proteins and most of the numerous fetal 
proteins described to date (32, 53-59). However, we can 
prove that these fetoproteins are neither al-fetoprotein, 
BOF A, or ferritin nor components due to cultivation in 
medium containing FCS (60). The cultures were main-
tained for 9 days without FCS, with two changes of 
medium, and desorption of FCS occurs at 3 days (61). 
Also, the antisera specific for BT 20 cells, which reveal 
these fetal proteins, do not precipitate any constituents 
of FCS. Moreover, both absorption of the anti-BT 20 
cells antisera by FCS and double diffusion in the 
presence of FCS did not change the results. 
Both BT 20 cells as well as neoplastic and dysplastic 
human mammary tissues synthesize these fetal antigens 
in relatively large amounts, as demonstrated by the 
intensity of the radiolabeled lines. These proteins can 
be classified in the group of oncofetal-associated anti-
gens described by Alexander (62). The synthesis of 
these oncofetal-associated antigens could be due to a 
derepression caused either by tumor transformation of 
the cells or by the tissue culture conditions, inasmuch 
as Parker et al. (63) have demonstrated that normal 
tissues can express new fetal antigens in vitro. Thus 
the in vivo importance of these oncofetal antigens 
remains to be determined. 
The results obtained are promising in that many 
products which are probably important as character-
istics of the breast carcinoma cells are synthesized as 
soluble antigens in vitro by BT 20 cells. Isolation and 
purification of these products are in progress in our 
laboratory; the preparation of antisera against these 
products could lead to their identification in various 
tissues. 
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FIGIIRE l.-Autoradiographs of agarose elec-
trophoresis of culture fluids from BT 20 cells 
cultured with [14C]lysine plus [14C]isoleucine, 
samples 1-4 (SI-54). At bottom. electrophore-
sis of normal human serum (NHS) as refer-
ence for electrophoretic mobilities. 
FI(;I'RE 2.-Autoradiographs of SDS poh-
acrylamide gel electrophoresis of culture 
fluids from BT 20 cells cultured with [14C]h-
sine plus [14C]isoleucine. From top to bot-
tom: samples 1-4. Markers are indicated: 
CYT=cytochrome c; OVA=ovalbumin; 
BSA=bovine serum albumin; DIM=dimer. 
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FIGURE 3.-Autoradiographs of immunoelectrophoresis of culture fluids from BT 20 cells. a) No carrier. antierythrocyte membrane (a-M ERY) 
and anti-BT 20 cell serum (a-BT 20). b) Glycophorin as carrier and antiglycophorin serum (a-GL). c) Human serum as carrier and anti-a2-
lipoprotein serum (a-LIPO). d) p2-microglobulin as carrier and anti-P2-microglobulin serum (a-p2 MICRO). Anode is on left. 
FIGI'RE 4.-Autoradiograph of double diffusion in agar. In an/er well. antiserum specific for glycophorin (a-GLY); in peripheral wells. cul-
ture fluids from 2 different cultures of BT 20 cells alone (0) or with glycophorin (GL) or spectrin (SP) as carriers. 
FIGURE 5.-Autoradiographs of double diffusion in agar. In anler well. culture fluid from BT 20 cells alone (fig. 5a) or with CEA as carrier 
(fig. 5b). In peripheral wells. anti-BT 20 cell sera and anti-CEA sera (a CEA). Labeled line of CEA is visible with CEA as carrier 
(arrowheads). 
FIGURE 6.-Autoradiographs of double diffusion in agar. Peripheral wells contain 3 different anti-BT 20 cell sera. Cenler well contains samples 
3 and 4 from BT 20 cells (BT 3 and BT 4). from 2 different placentas (PLA). and from fetal intestine (INT) and fetal submandibular gland 
(SM). 
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